Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
The study showed a 76% complete response (CR) rate at 12 months, rising to 95% at any time for high-risk NMIBC patients
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
Subscribe To Our Newsletter & Stay Updated
